In addition, intriguingly, low-expression of CHD7 was correlated to the survival of gemcitabine treated pancreatic ductal adenocarcinoma patients [39], suggesting the potential of CHD7 as a tumor suppresser gene like CHD5 in some tumors. This evidence concerns the gene CHD5 and neoplasm.